Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Mol Life Sci. 2013 Nov;70(21):4085-99. doi: 10.1007/s00018-013-1327-z. Epub 2013 Apr 12.

Life in the Fas lane: differential outcomes of Fas signaling.

Author information

1
Department of Pathology, University College Cork, National University of Ireland, Cork, Ireland.

Abstract

Fas, also known as CD95 or APO-1, is a member of the tumor necrosis factor/nerve growth factor superfamily. Although best characterized in terms of its apoptotic function, recent studies have identified several other cellular responses emanating from Fas. These responses include migration, invasion, inflammation, and proliferation. In this review, we focus on the diverse cellular outcomes of Fas signaling and the molecular switches identified to date that regulate its pro- and anti-apoptotic functions. Such switches occur at different levels of signal transduction, ranging from the receptor through to cross-talk with other signaling pathways. Factors identified to date including other extracellular signals, proteins recruited to the death-inducing signaling complex, and the availability of different intracellular components of signal transduction pathways. The success of therapeutically targeting Fas will require a better understanding of these pathways, as well as the regulatory mechanisms that determine cellular outcome following receptor activation.

PMID:
23579628
DOI:
10.1007/s00018-013-1327-z
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center